At a glance
ClinicalIndex Comparison RecordN/ACompleted· 84 enrolled
Drug / intervention
Naloxone +1 moredrug
Likely dose
Naloxone 0.5 mcg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Two Naloxone Infusion Rates on the Postoperative Recovery of Patients Undergoing Spine Fusion Surgery
In Brief
A clinical study evaluating Naloxone for Pain, Postoperative and 2 related conditions. Completed, enrolled 84 participants across 1 site.
Detailed Summary
There will be two groups in this study: one group will be given the standard infusion of naloxone, a drug which helps reduce side effects from opioids needed after surgery, and the other group will receive a higher dose. The trial is designed to determine if a higher dose of naloxone infusion will reduce side effects from opioid therapy in patients who have undergone spine fusion for scoliosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
First PostedFeb 2012
Primary CompletionMay 2015
Study CompletionDec 2016
TodayJul 2026
First PostedFeb 13, 2012
Enrollment StartNov 1, 2011
Primary CompletionMay 1, 2015
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 14.4 years ago
Interventions
Naloxonedrug
Naloxone infusion 0.5 mcg/kg/hr
Naloxonedrug
Naloxone infusion 2.5 mcg/kg/hr